Yao Huang

Xihong Road 312
Fuzhou, 350025, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Integrated Radioproteomic Modeling for Early Recurrence Prediction and Metabolic Characterization in Hepatocellular Carcinoma.

Integrated Radioproteomic Modeling for Early Recurrence Prediction and Metabolic Characterization in Hepatocellular Carcinoma.

Journal: JCO precision oncology

Published: July 29, 2026

Assessment of road accessibility to medical demand points under the influence of specific speed reduction parameter settings.

Assessment of road accessibility to medical demand points under the influence of specific speed reduction parameter settings.

Journal: Traffic injury prevention

Published: May 15, 2026

Biomimetic β-lapachone and hemin nanoassembly for intracellular oxidation cascade amplified ferroptosis in hepatocellular carcinoma therapy.

Biomimetic β-lapachone and hemin nanoassembly for intracellular oxidation cascade amplified ferroptosis in hepatocellular carcinoma therapy.

Journal: Journal of nanobiotechnology

Published: February 28, 2026

Overcoming Tumor Hypoxia and Adenosine-mediated Immunosuppression for Boosting Photodynamic Therapy and Systemic Antitumor Immune Responses.

Overcoming Tumor Hypoxia and Adenosine-mediated Immunosuppression for Boosting Photodynamic Therapy and Systemic Antitumor Immune Responses.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: January 12, 2026

Rare-earth cerium-coordinated ICG nanoprobe for tumor hypoxia relief and intensified photodynamic therapy.

Rare-earth cerium-coordinated ICG nanoprobe for tumor hypoxia relief and intensified photodynamic therapy.

Journal: Materials today. Bio

Published: November 24, 2025

A Dual-Metabolic NIR-II Probe for In Vivo Imaging of Tumor-Infiltrating Lymphocytes.

A Dual-Metabolic NIR-II Probe for In Vivo Imaging of Tumor-Infiltrating Lymphocytes.

Journal: Advanced healthcare materials

Published: November 13, 2025

Multi-omics SMR and experimental supportive analyses decipher causal drivers hepatocellular carcinoma.

Multi-omics SMR and experimental supportive analyses decipher causal drivers hepatocellular carcinoma.

Journal: BMC cancer

Published: October 23, 2025

Multi-omics SMR and experimental supportive analyses decipher causal drivers hepatocellular carcinoma.

Multi-omics SMR and experimental supportive analyses decipher causal drivers hepatocellular carcinoma.

Journal: BMC cancer

Published: October 23, 2025

AdvanTIG-206: a phase II, randomized study of ociperlimab plus tislelizumab and BAT1706 (bevacizumab biosimilar) versus tislelizumab and BAT1706 in first-line hepatocellular carcinoma.

AdvanTIG-206: a phase II, randomized study of ociperlimab plus tislelizumab and BAT1706 (bevacizumab biosimilar) versus tislelizumab and BAT1706 in first-line hepatocellular carcinoma.

Journal: Cancer immunology, immunotherapy : CII

Published: September 03, 2025

E2F2/MUC1 Enhances Cell Stemness of Hepatocellular Carcinoma by Regulating the Notch Signaling Pathway.

E2F2/MUC1 Enhances Cell Stemness of Hepatocellular Carcinoma by Regulating the Notch Signaling Pathway.

Journal: Digestive diseases and sciences

Published: March 24, 2025

Bifunctional thiourea-based additives for synergistic enhancement of perovskite crystallization and defect density optimization.

Bifunctional thiourea-based additives for synergistic enhancement of perovskite crystallization and defect density optimization.

Journal: Journal of colloid and interface science

Published: February 24, 2025

ARHGEF39 targeted by E2F1 fosters hepatocellular carcinoma metastasis by mediating fatty acid metabolism.

ARHGEF39 targeted by E2F1 fosters hepatocellular carcinoma metastasis by mediating fatty acid metabolism.

Journal: Clinics and research in hepatology and gastroenterology

Published: March 14, 2024

Showing 1-12 of 29

Last Updated: 09/26/2026